-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WlgAyZTB/V94TdQM4C0gyXujFJQ4bh6vyed8Qj0iadY0Bg+mNQ1VtdhT5FqHT/g6 WK+NfufaHAnfO2aehPgw5w== 0000950120-98-000421.txt : 19981126 0000950120-98-000421.hdr.sgml : 19981126 ACCESSION NUMBER: 0000950120-98-000421 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 19981125 GROUP MEMBERS: BRUCE F. WESSON GROUP MEMBERS: DAVID JAHNS GROUP MEMBERS: GALEN EMPLOYEE FUND III, L.P. GROUP MEMBERS: GALEN PARTNERS III L P GROUP MEMBERS: GALEN PARTNERS INTERNATIONAL III, L.P. GROUP MEMBERS: L. JOHN WILKERSON GROUP MEMBERS: SRINI CONJEEVARAM GROUP MEMBERS: WILLIAM R. GRANT SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Q MED INC CENTRAL INDEX KEY: 0000729213 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 222468665 STATE OF INCORPORATION: DE FISCAL YEAR END: 1130 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: SEC FILE NUMBER: 005-34953 FILM NUMBER: 98759840 BUSINESS ADDRESS: STREET 1: 100 METRO PARK S STREET 2: 3RD FLOOR CITY: LAURENCE HARBOR STATE: NJ ZIP: 08878 BUSINESS PHONE: 9085662666 MAIL ADDRESS: STREET 1: 100 METRO PARK SOUTH CITY: LAURENCE STATE: NJ ZIP: 08878 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: GALEN PARTNERS III L P CENTRAL INDEX KEY: 0001034486 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 133930452 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 610 FIFTH AVE STREET 2: 5TH FL CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: 2122184990 MAIL ADDRESS: STREET 1: 610 FIFTH AVE STREET 2: 5TH FL CITY: NEW YORK STATE: NY ZIP: 10020 SC 13D/A 1 AMENDMENT NO. 1 TO SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 AMENDMENT NO. 1 TO SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 Q-MED, INC. ----------- (Name of Issuer) COMMON STOCK, $.001 PAR VALUE PER SHARE --------------------------------------- (Title of Class of Securities) 74791410 --------------------- (CUSIP Number) Bruce F. Wesson Senior Managing Member Claudius, L.L.C. 610 Fifth Avenue, 5th Floor New York, NY 10020 (212) 218-4990 -------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) NOVEMBER 16, 1998 ------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this Schedule because of Rule 13d- 1(b)(3) or (4), check the following box [ ]. Note: Six copies of this statement, including all exhibits, should be filed with the Commission. See Rule 13d-1(a) for other parties to whom copies are to be sent. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the "Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all provisions of the Act (however, see the Notes). Page 1 of 17 Pages Pages 2 through 9 of the initial Schedule 13D pertaining to the Common Stock of Q-Med, Inc., a Delaware corporation, filed with the Securities and Exchange Commission ("SEC") on March 30, 1998 for an event on March 18, 1998 (the "Initial Schedule 13D") are hereby amended to read in their entirety as follows: SCHEDULE 13D CUSIP NO. 74791410 PAGE 2 OF 17 PAGES ------------- --- ---- ------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Galen Partners III, L.P. ------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [X] ------------------------------------------------------------------- 3 SEC USE ONLY ------------------------------------------------------------------- 4 SOURCE OF FUNDS WC ------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(E) [ ] ------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware ------------------------------------------------------------------- 7 SOLE VOTING POWER NUMBER OF 2,177,634 (see Item 5(a)) SHARES ----------------------------------------------------- 8 SHARED VOTING POWER BENEFICIALLY 0 OWNED BY ----------------------------------------------------- 9 SOLE DISPOSITIVE POWER EACH 2,177,634 REPORTING ----------------------------------------------------- 10 SHARED DISPOSITIVE POWER PERSON WITH 0 ------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,177,634 ------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] ------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 17.1% ------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON PN ------------------------------------------------------------------- SCHEDULE 13D CUSIP NO. 74791410 PAGE 3 OF 17 PAGES ------------- --- ---- ------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Galen Partners International III, L.P. ------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [X] ------------------------------------------------------------------- 3 SEC USE ONLY ------------------------------------------------------------------- 4 SOURCE OF FUNDS WC ------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(E) [ ] ------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware ------------------------------------------------------------------- 7 SOLE VOTING POWER NUMBER OF 197,113 (see Item 5(a)) SHARES ----------------------------------------------------- 8 SHARED VOTING POWER BENEFICIALLY 0 OWNED BY ----------------------------------------------------- 9 SOLE DISPOSITIVE POWER EACH 197,113 REPORTING ----------------------------------------------------- 10 SHARED DISPOSITIVE POWER PERSON WITH 0 ------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 197,113 ------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] ------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 1.5% ------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON PN ------------------------------------------------------------------- SCHEDULE 13D CUSIP NO. 74791410 PAGE 4 OF 17 PAGES ------------- --- ---- ------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Galen Employee Fund III, L.P. ------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [X] ------------------------------------------------------------------- 3 SEC USE ONLY ------------------------------------------------------------------- 4 SOURCE OF FUNDS WC ------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(E) [ ] ------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware ------------------------------------------------------------------- 7 SOLE VOTING POWER NUMBER OF 9,477 (see Item 5(a)) SHARES ----------------------------------------------------- 8 SHARED VOTING POWER BENEFICIALLY 0 OWNED BY ----------------------------------------------------- 9 SOLE DISPOSITIVE POWER EACH 9,477 REPORTING ----------------------------------------------------- 10 SHARED DISPOSITIVE POWER PERSON WITH 0 ------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9,477 ------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] ------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.1% ------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON PN ------------------------------------------------------------------- SCHEDULE 13D CUSIP NO. 74791410 PAGE 5 OF 17 PAGES ------------- --- ---- ------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON William R. Grant ------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [X] ------------------------------------------------------------------- 3 SEC USE ONLY ------------------------------------------------------------------- 4 SOURCE OF FUNDS PF ------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(E) [ ] ------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION U.S. ------------------------------------------------------------------- 7 SOLE VOTING POWER NUMBER OF 13,334 (see Item 5(a)) SHARES ----------------------------------------------------- 8 SHARED VOTING POWER BENEFICIALLY 0 OWNED BY ----------------------------------------------------- 9 SOLE DISPOSITIVE POWER EACH 13,334 REPORTING ----------------------------------------------------- 10 SHARED DISPOSITIVE POWER PERSON WITH 0 ------------------------------------------------------------------ 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 13,334 ------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] ------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.1% ------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON IN ------------------------------------------------------------------- SCHEDULE 13D CUSIP NO. 74791410 PAGE 6 OF 17 PAGES ------------- --- ---- ------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Bruce F. Wesson ------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [X] ------------------------------------------------------------------- 3 SEC USE ONLY ------------------------------------------------------------------- 4 SOURCE OF FUNDS PF ------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(E) [ ] ------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION U.S. ------------------------------------------------------------------- 7 SOLE VOTING POWER NUMBER OF 38,333 (see Item 5(a)) SHARES ----------------------------------------------------- 8 SHARED VOTING POWER BENEFICIALLY 0 OWNED BY ----------------------------------------------------- 9 SOLE DISPOSITIVE POWER EACH 38,333 REPORTING ----------------------------------------------------- 10 SHARED DISPOSITIVE POWER PERSON WITH 0 ------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 38,333 ------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] ------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.3% ------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON IN ------------------------------------------------------------------- SCHEDULE 13D CUSIP NO. 74791410 PAGE 7 OF 17 PAGES ------------- --- ---- ------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON L. John Wilkerson ------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [X] ------------------------------------------------------------------- 3 SEC USE ONLY ------------------------------------------------------------------- 4 SOURCE OF FUNDS PF ------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(E) [ ] ------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION U.S. ------------------------------------------------------------------- 7 SOLE VOTING POWER NUMBER OF 38,333 (see Item 5(a)) SHARES ----------------------------------------------------- 8 SHARED VOTING POWER BENEFICIALLY 0 OWNED BY ----------------------------------------------------- 9 SOLE DISPOSITIVE POWER EACH 38,333 REPORTING ----------------------------------------------------- 10 SHARED DISPOSITIVE POWER PERSON WITH 0 ------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 38,333 ------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] ------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.3% ------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON IN ------------------------------------------------------------------ SCHEDULE 13D CUSIP NO. 74791410 PAGE 8 OF 17 PAGES ------------- --- ---- ------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Srini Conjeevaram ------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [X] ------------------------------------------------------------------- 3 SEC USE ONLY ------------------------------------------------------------------- 4 SOURCE OF FUNDS PF ------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(E) [ ] ------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION India (see Item 2) ------------------------------------------------------------------- 7 SOLE VOTING POWER NUMBER OF 9,000 (see Item 5(a)) SHARES ----------------------------------------------------- 8 SHARED VOTING POWER BENEFICIALLY 0 OWNED BY ----------------------------------------------------- 9 SOLE DISPOSITIVE POWER EACH 9,000 REPORTING ----------------------------------------------------- 10 SHARED DISPOSITIVE POWER PERSON WITH 0 ------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9,000 ------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] ------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.1% ------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON IN ------------------------------------------------------------------- SCHEDULE 13D CUSIP NO. 74791410 PAGE 9 OF 17 PAGES ------------- --- ---- ------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON David Jahns ------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [X] ------------------------------------------------------------------- 3 SEC USE ONLY ------------------------------------------------------------------- 4 SOURCE OF FUNDS PF ------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(E) [ ] ------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION U.S. ------------------------------------------------------------------- 7 SOLE VOTING POWER NUMBER OF 9,000 (see Item 5(a)) SHARES ----------------------------------------------------- 8 SHARED VOTING POWER BENEFICIALLY 0 OWNED BY ----------------------------------------------------- 9 SOLE DISPOSITIVE POWER EACH 9,000 REPORTING ----------------------------------------------------- 10 SHARED DISPOSITIVE POWER PERSON WITH 0 ------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9,000 ------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] ------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.1% ------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON IN ------------------------------------------------------------------- ITEM 1. SECURITY AND ISSUER. The first paragraph of Item 1 of the Initial Schedule 13D is hereby amended to read in its entirety as follows: This statement covers a total of 2,492,224 fully diluted shares of Common Stock, $.001 par value per share (the "Common Stock"), of Q-Med, Inc., a Delaware corporation (the "Issuer"). The Reporting Persons (as defined in Item 2 hereof) as of the date hereof hold an aggregate of (i) 1,315,363 shares of Common Stock (the "Common Shares"), (ii) $950,000 principal amount of Convertible Notes of the Issuer (the "Notes"), which as of the date hereof are convertible into an aggregate of 568,861 shares of Common Stock, and (iii) warrants for the purchase of 607,999 shares of Common Stock (the "Warrants"), which as of the date hereof may be exercised for an aggregate of 607,999 shares of Common Stock. The Common Shares, Notes and Warrants are referred to herein, collectively, as the "Securities". ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION. Item 3 of the Initial Schedule 13D is hereby amended to read in its entirety as follows: The funds for the acquisition of the Common Shares were allocated from the working capital of the Partnership Reporting Persons and were not obtained by means of a loan or other borrowing arrangement. The Common Shares were acquired by the Partnership Reporting Persons at a purchase price of $1.67 per share for an aggregate amount of $1,000,000 in cash plus the exchange of approximately $1,200,000 amount of principal and accrued interest on Notes of the Issuer held by them. The Warrants, which are exercisable at a price equal to the average of the market price of the Issuer's common stock for the ten trading days following issuance, were issued as partial consideration for the exchange by the Partnership Reporting Persons of the aforesaid convertible notes held by them. Each of the Partnership Reporting Persons paid its pro rata share of the acquisition price of the Common Shares based upon the number of Common Shares it received. -10- ITEM 5. INTEREST IN SECURITIES OF THE ISSUER. Item 5, subpart (a) of the Initial Schedule 13D is hereby amended to read in its entirety as follows: (a) Each Reporting Person owns or has the right to acquire the number of securities shown opposite its name: ======================================================================= (1) (2) (3) (4) (5) (6) Number of Shares of Common Stock which Number of may be Shares of acquired Percentage of Number of Common pursuant Outstanding Shares of Stock into to Total of Shares of Common which Owned exercise Columns Common Stock Reporting Stock Notes are of Owned (2), (3) (see Note Person Owned Convertible Warrants and (4) below) ----------------------------------------------------------------------- Galen 1,201,389 519,570 456,675 2,177,634 17.1% ----------------------------------------------------------------------- Galen Intl 108,746 47,030 41,337 197,113 1.5% ----------------------------------------------------------------------- GEF 5,228 2,261 1,988 9,477 0.1% ----------------------------------------------------------------------- Grant 0 0 13,334 13,334 0.1% ----------------------------------------------------------------------- Wesson 0 0 38,333 38,333 0.3% ----------------------------------------------------------------------- Wilkerson 0 0 38,333 38,333 0.3% ----------------------------------------------------------------------- Conjeevaram 0 0 9,000 9,000 0.1% ----------------------------------------------------------------------- Jahns 0 0 9,000 9,000 0.1% ----------------------------------------------------------------------- Total 1,315,363 568,861 608,000 2,492,224 19.5% ======================================================================= Note: The percentages shown in each row of column (6) were calculated, for each respective row, by (i) adding the totals in the bottom row of columns (3) and (4) to 11,586,221 (the number of shares of Common Stock outstanding as of November 16, 1997, such number having been provided by the Issuer to the Reporting Persons) (the "Total Adjusted Outstanding Shares"), then (ii) dividing the amount in column (5) by the Total Adjusted Outstanding Shares, and then (iii) expressing such quotient in terms of a percentage. -11- ITEM 7. MATERIAL TO BE FILED AS EXHIBITS. Item 7 of the Initial Schedule 13D is hereby amended to add the folowing Exhibit 2: 2. Joint Filing Agreement and Power of Attorney, dated November 23, 1998, by the Reporting Persons and the Related Persons. -12- SIGNATURE --------- After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in the statement is true, complete and correct. Date: November 23, 1998 GALEN PARTNERS III, L.P. By: Claudius, L.L.C. By: /s/ Bruce F. Wesson ----------------------------- Senior Managing Member GALEN PARTNERS INTERNATIONAL III, L.P. By: Claudius, L.L.C. By: /s/ Bruce F. Wesson ----------------------------- Senior Managing Member GALEN EMPLOYEE FUND III, L.P. By: Wesson Enterprises, Inc. By: /s/ Bruce F. Wesson ----------------------------- President [Signatures continued on next page.] -13- /s/ William R. Grant -------------------------------- WILLIAM R. GRANT /s/ Bruce F. Wesson -------------------------------- BRUCE F. WESSON /s/ L. John Wilkerson -------------------------------- L. JOHN WILKERSON /s/ David Jahns -------------------------------- DAVID JAHNS /s/ Srini Conjeevaram -------------------------------- SRINI CONJEEVARAM /s/ Zubeen Shroff -------------------------------- ZUBEEN SHROFF CLAUDIUS, L.L.C. By: /s/ Bruce F. Wesson ------------------------------ Senior Managing Member WESSON ENTERPRISES, INC. By: /s/ Bruce F. Wesson ------------------------------ President -14- EXHIBIT INDEX Exhibit Description ------- ----------- 2 Joint Filing Agreement and Power of Attorney, dated November 23, 1998, by the Reporting Persons and the Related Persons -15- EX-99 2 EXHIBIT 2 Exhibit 2 JOINT FILING AGREEMENT ---------------------- AND POWER OF ATTORNEY --------------------- In accordance with Rule 13d-1(f) under the Securities Exchange Act of 1934, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including exhibits and thereto) with respect to the acquisition of, or the right to acquire, the Common Stock of Q-Med, Inc. a Delaware corporation. This Agreement shall be included as an Exhibit to such joint filing. In evidence thereof, each of the undersigned, being duly authorized, hereby executes this Agreement as of the 23rd day of November, 1998. Each person whose signature appears below hereby constitutes and appoints Bruce F. Wesson as his or its true and lawful attorney-in-act and agent, with full power and authority, including power of substitution and resubstitution, and in his or its name, place and stead in any and all capacities, to execute in the name of each such person, and to file, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, any and all amendments to this Statement on Schedule 13D as such attorney-in-fact and agent, or its substitutes, executing such amendments deem necessary or advisable to enable each person whose signature appears below to comply with the Securities Exchange Act of 1934 and any rules, regulations and requirements of the Securities and Exchange Commission in respect thereof, granting to said attorney-in-fact, agents and substitutes full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intends and purposes as they might or cold do in person, and does hereby ratify and confirm all that such attorney-in-fact, agents or substitutes, or any of the separately, may lawfully do os cause to b done by virtue thereof. GALEN PARTNERS III, L.P. By: Claudius, L.L.C. By: /s/ Bruce F. Wesson ----------------------------- Senior Managing Member GALEN PARTNERS INTERNATIONAL III, L.P. By: Claudius, L.L.C. By: /s/ Bruce F. Wesson ----------------------------- Senior Managing Member -16- GALEN EMPLOYEE FUND III, L.P. By: Wesson Enterprises, Inc. By: /s/ Bruce F. Wesson ----------------------------- President /s/ William R. Grant -------------------------------- WILLIAM R. GRANT /s/ Bruce F. Wesson -------------------------------- BRUCE F. WESSON /s/ L. John Wilkerson -------------------------------- L. JOHN WILKERSON /s/ David Jahns -------------------------------- DAVID JAHNS /s/ Srini Conjeevaram -------------------------------- SRINI CONJEEVARAM /s/ Zubeen Shroff -------------------------------- ZUBEEN SHROFF CLAUDIUS, L.L.C. By: /s/ Bruce F. Wesson ------------------------------ Senior Managing Member WESSON ENTERPRISES, INC. By: /s/ Bruce F. Wesson ------------------------------ President -17- -----END PRIVACY-ENHANCED MESSAGE-----